02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
U.S. Citizenship and Immigration Services (USCIS) opened its initial registration period for the fis...
Read More >
Congress recently passed the economic stimulus package referred to as the Coronavirus Aid, Relief, a...
Read More >
Anyone who works in legal or HR and handles work authorizations for their employees will agree that ...
Read More >
Since the COVID epidemic took hold there has been a significant reduction in the number of law firm ...
Read More >
Many construction contracts include a clause that allows an owner to terminate a contractor’s remai...
Read More >
On June 18, 2019, the Federal Trade Commission (FTC) hosted a workshop to discuss and analyze the ef...
Read More >